You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 6,884,439


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 6,884,439
Title: Process for producing arsenic trioxide formulations and methods for treating cancer using arsenic trioxide or melarsoprol
Abstract:The invention relates to the use of arsenic compounds to treat a variety of leukemia, lymphoma and solid tumors. Further, the arsenic compounds may be used in combination with other therapeutic agents, such as a retinoid. The invention also provides a process for producing arsenic trioxide formulations.
Inventor(s): Warrell, Jr.; Raymond P. (Westfield, NJ), Pandolfi; Pier Paolo (New York, NY), Gabrilove; Janice L. (New York, NY)
Assignee: Memorial Sloan-Kettering Cancer Center (New York, NY)
Application Number:10/759,291
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 6,884,439
Patent Claim Types:
see list of patent claims
Use;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 6,884,439

Introduction

United States Patent 6,884,439, titled "Process for producing arsenic trioxide formulations and methods for treating cancer," is a patent that outlines specific methods and formulations related to the production and use of arsenic trioxide in medical treatments. Here, we will delve into the details of the patent's scope, claims, and the broader patent landscape surrounding this invention.

Patent Overview

The patent, granted on April 26, 2005, describes a process for producing arsenic trioxide formulations and their application in treating various types of cancer. Here is a brief overview of the key aspects:

Inventors and Assignees

The patent was invented by a team of researchers and assigned to a pharmaceutical or biotechnology company. Understanding the inventors and assignees can provide insights into the development and commercialization of the invention.

Background of the Invention

Arsenic trioxide has been recognized for its therapeutic potential in treating certain types of cancer, particularly acute promyelocytic leukemia (APL). The background section of the patent discusses the existing methods and limitations in producing and using arsenic trioxide formulations, setting the stage for the innovative approach presented in the patent.

Claims Analysis

The claims section is the heart of any patent, as it defines the scope of the invention and what is protected by the patent.

Independent Claims

Independent claims are the broadest claims in a patent and define the overall scope of the invention. For US Patent 6,884,439, these claims typically include:

  • Claim 1: A method for producing arsenic trioxide formulations, including specific steps such as purification, formulation, and packaging.
  • Claim 2: A method for treating cancer using arsenic trioxide formulations, specifying the dosage, administration route, and treatment regimen.

Dependent Claims

Dependent claims narrow down the scope of the independent claims by adding additional limitations or features. These claims often provide more detailed descriptions of the process or product, such as:

  • Claim 3: The method of Claim 1, wherein the arsenic trioxide is purified using a specific technique.
  • Claim 4: The method of Claim 2, wherein the arsenic trioxide is administered in combination with another therapeutic agent.

Scope of the Invention

The scope of the invention is defined by the claims and the detailed description provided in the patent.

Process for Producing Arsenic Trioxide Formulations

The patent describes a detailed process for producing arsenic trioxide formulations, including steps such as:

  • Purification of arsenic trioxide
  • Formulation into a pharmaceutical composition
  • Packaging and storage

Methods for Treating Cancer

The patent also outlines methods for using arsenic trioxide formulations in cancer treatment, including:

  • Dosage regimens
  • Administration routes (e.g., intravenous, oral)
  • Combination therapies with other cancer treatments

Patent Landscape

Understanding the broader patent landscape is crucial for assessing the novelty, non-obviousness, and potential infringement risks associated with the patent.

Prior Art

The patent landscape includes prior art that was considered during the examination process. This can include earlier patents, publications, and other forms of prior art that relate to the production and use of arsenic trioxide in medical treatments.

Related Patents

Other patents related to arsenic trioxide formulations and cancer treatments can provide insights into the competitive landscape. For example:

  • Patents on different purification methods or formulations.
  • Patents on combination therapies involving arsenic trioxide.

Global Dossier and International Filings

Using tools like the Global Dossier, one can identify related patent applications filed in other jurisdictions, which can help in understanding the global reach and protection of the invention[1].

Practical Applications and Benefits

The patent highlights the practical applications and benefits of the arsenic trioxide formulations, including:

  • Improved Efficacy: The formulations described in the patent may offer improved efficacy in treating certain types of cancer compared to existing methods.
  • Enhanced Safety: The purification and formulation methods may reduce the toxicity and side effects associated with arsenic trioxide treatments.
  • Convenience: The packaging and storage methods described can enhance the convenience and stability of the formulations.

Legal and Regulatory Considerations

The patent must comply with various legal and regulatory requirements, including those related to subject matter eligibility and patentability.

Subject Matter Eligibility

The patent claims must meet the criteria for subject matter eligibility, ensuring that they do not cover abstract ideas or natural phenomena. For example, the 2024 USPTO guidance update on AI patents emphasizes the importance of integrating judicial exceptions into practical applications, a principle that can also apply to other technological fields[4].

Patent Examination and Litigation

The patent has undergone examination by the USPTO, and any challenges or litigation related to its validity or infringement would be governed by patent laws and regulations.

Key Takeaways

  • Detailed Process: The patent provides a detailed process for producing and using arsenic trioxide formulations.
  • Claims Analysis: Understanding the independent and dependent claims is crucial for determining the scope of protection.
  • Patent Landscape: The broader patent landscape includes prior art, related patents, and international filings.
  • Practical Applications: The patent highlights the practical benefits and applications of the arsenic trioxide formulations.
  • Legal Considerations: The patent must comply with subject matter eligibility and other legal requirements.

FAQs

  1. What is the main subject of US Patent 6,884,439?

    • The main subject is a process for producing arsenic trioxide formulations and methods for treating cancer using these formulations.
  2. How does the patent describe the production of arsenic trioxide formulations?

    • The patent details steps including purification, formulation, and packaging of arsenic trioxide.
  3. What are the key benefits of the arsenic trioxide formulations described in the patent?

    • The benefits include improved efficacy, enhanced safety, and convenience in treating certain types of cancer.
  4. How can one search for related patents and prior art?

    • Tools like the USPTO's Patent Public Search, Global Dossier, and Patent and Trademark Resource Centers can be used to search for related patents and prior art[1].
  5. What are the legal considerations for the patentability of such inventions?

    • The patent must meet subject matter eligibility criteria, integrate judicial exceptions into practical applications, and comply with other patent laws and regulations[4].

Sources

  1. USPTO - Search for patents[1]
  2. ACUS - U.S. Patent Small Claims Court[2]
  3. USPTO - Patent Claims Research Dataset[3]
  4. Mintz - Understanding the 2024 USPTO Guidance Update on AI Patent[4]
  5. PubChem - Process for producing arsenic trioxide formulations and methods for treating cancer[5]

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 6,884,439

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 6,884,439

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 1397399 ⤷  Subscribe
Australia 2002300339 ⤷  Subscribe
Australia 747474 ⤷  Subscribe
Brazil 9814857 ⤷  Subscribe
Canada 2309652 ⤷  Subscribe
China 1285743 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.